QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9667723F46F28605F09734A99CA4DA2;jsessionid=6961CF836CF5728373E2183EADAB2533;jsessionid=2895DFEDBF1325C8CD2C502532774450;jsessionid=64966F5F51490D4981A3C51DFEFC90B7;jsessionid=38942594FA88BC845E77594F4DA2BE39;jsessionid=E354AFD3A63AF1ED43F386ED13156033;jsessionid=C7C22D789D499BAD44BD7716E6FEAB3B;jsessionid=9BFE2BA3305DBE6EFF72A2F88E6D198C;jsessionid=76993A227D98A68E7DE202C77AEBB6DA;jsessionid=4BF3BA373F51DCAF85F4D8234E619A4A (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9667723F46F28605F09734A99CA4DA2;jsessionid=6961CF836CF5728373E2183EADAB2533;jsessionid=2895DFEDBF1325C8CD2C502532774450;jsessionid=64966F5F51490D4981A3C51DFEFC90B7;jsessionid=38942594FA88BC845E77594F4DA2BE39;jsessionid=E354AFD3A63AF1ED43F386ED13156033;jsessionid=C7C22D789D499BAD44BD7716E6FEAB3B;jsessionid=9BFE2BA3305DBE6EFF72A2F88E6D198C;jsessionid=76993A227D98A68E7DE202C77AEBB6DA;jsessionid=4BF3BA373F51DCAF85F4D8234E619A4A